Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.06 | N/A |
| PEG Ratio (TTM) | -6.91 | N/A |
| P/S Ratio (TTM) | 1.20 | N/A |
| P/B Ratio (TTM) | 2.35 | N/A |
| P/FCF Ratio (TTM) | 15.83 | N/A |
| Price to 5YR AVG Earnings Ratio | 23.25 | N/A |
| Price to 5YR AVG FCF Ratio | 26.02 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.89% | N/A |
| ROE (TTM) | 17.55% | N/A |
| Net Profit Margin (TTM) | 8.52% | N/A |
| ROIC 5YR AVG | 13.91% | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.21% | 33.17% | 33.37% |
| Revenue | 0.98% | -0.59% | 2.44% |
| Net Income | -0.06% | 34.41% | 34.11% |
| Cash Flow | 132.06% | 9.29% | 148.46% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.17 | N/A |
| Quick Ratio (TTM) | 1.43 | N/A |
| D/E Ratio (TTM) | 0.32 | N/A |
| Interest Coverage (TTM) | 13.18 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 4.03 | N/A |
| LTL to 5YR AVG FCF | 3.78 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.63% | N/A |